Effect of Maraviroc on HIV Disease Progression-Related Biomarkers

The potential effect of blocking the CCR5 receptor on HIV disease progression biomarkers is not well understood. We showed that an 8-day maraviroc (MVC) monotherapy clinical test (MCT) can be used in selecting patients to receive MVC-containing combined antiretroviral therapy (cART). Using this MCT...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Romero-Sánchez, M. Concepción, Machmach, Kawthar, Gonzalez-Serna, Alejandro, Genebat, Miguel, Pulido, Ildefonso, García-García, María, Álvarez-Ríos, Ana Isabel, Ferrando-Martinez, Sara, Ruiz-Mateos, Ezequiel, Leal, Manuel
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3486555/
https://ncbi.nlm.nih.gov/pubmed/22948867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01406-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados